Optimus Pharma launched a new Anti-Parkinson’s Drug in India

Hyderabad (Telangana) [India], April 26: Optimus Pharma has announced today that it has received DCGI approval for its Anti-Parkinson’s drug Safinamide. Safinamide is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes. The burdens of Parkinson’s Disease (PD) are undeniably serious and increasing while various unmet needs remain, especially